1. Will other drugmakers end up with deals like Endo’s $10M opioid settlement? — AstraZeneca Imfinzi combo fails advanced lung cancer study — FDA says they were “lucky” with Novartis data manipulation controversy — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice
moderatora
Last Activity:
Sep 6, 2017 at 10:52 PM
Joined:
Apr 16, 2013
Messages:
0
Likes Received:
0
Trophy Points:
0

Share This Page

moderatora

Super Moderator

Staff Member
moderatora was last seen:
Sep 6, 2017 at 10:52 PM